We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Neurosenescence, inflammaging and neuroinflammation in neurodegenerative disorders
Summary
This review paper summarizes existing research showing that as we age, our brain cells and immune system deteriorate in ways that may contribute to diseases like Alzheimer's and Parkinson's. The aging process causes harmful inflammation in the brain, and scientists have identified specific biological markers that signal this damage is happening. Understanding these aging patterns could help researchers develop new treatments called "senolytic therapies" that target and remove damaged aging cells to potentially slow or prevent brain diseases.
Senescence is the biological aging associated with the gradual deterioration of cells and functions of various organs over time. This irreversible process is caused by genetic, metabolic, and environmental factors, such as telomere shortening, exposure to cytotoxic substances, and accumulated cellular damage over time, although the rate of degradation can be modified by lifestyle factors. Immunosenescence specifically refers to senescent changes in the innate and adaptive immunity and is associated with low inflammation known as inflammaging. As immunosenescence implies, reduced immune function leads to impaired tissue function and an increased risk of infection and heightened susceptibility to chronic, autoimmune, and neurodegenerative disorders, such as Alzheimer’s disease (AD) in the elderly. An increase in senescent cells is common in aging, which leads to age-associated diseases. Cellular senescence may also contribute to the onset and severity of Parkinson’s disease (PD) neuropathology. Inflammaging with high levels of proinflammatory marker expression may result from changes in immune responses, chronic antigenic stimulation, and senescence-associated secretory phenotype (SASP) factors, such as increased expression of interleukin-6 (IL-6), insulin-like growth factor binding proteins (IGFBPs), transforming growth factor-beta (TGF-β) and matrix metalloproteinase-10 (MMP-10) has been reported in AD patients. The levels of the senescence marker p16INK4a and several SASP factors, such as MMP-3, IL-6, IL-1α and IL-8 are elevated along with low levels of astrocytic lamin B1 in the substantia nigra of PD. This review discusses recent developments in neurosenescence and immunosenescence in AD and PD, as well as potential senolytic therapies.
Sign in to start a discussion.
More Papers Like This
Signs of Alzheimer’s Disease: Tied to Aging
This review explores the core biological mechanisms that connect aging to Alzheimer's disease, including abnormal protein buildup, chronic brain inflammation, loss of key neurotransmitters, and blood-brain barrier dysfunction. Researchers highlight how age-related decline in the body's ability to clear waste and repair cellular damage accelerates the progression of neurodegeneration. The study underscores the need for treatments that target multiple pathways simultaneously rather than addressing a single mechanism.
Uncovering the impact of nano- and microplastics on neurodegenerative diseases and strategies to mitigate their damage
Researchers reviewed evidence that micro- and nanoplastics may contribute to the progression of Alzheimer's and Parkinson's diseases by triggering brain inflammation, disrupting mitochondria (the cell's power source), and damaging the blood-brain barrier. The review also found that natural compounds like melatonin and probiotics show early promise in reducing some of these harmful effects.
The role of microplastics exposure in Alzheimer’s and Parkinson’s disease
Researchers reviewed the mechanistic links between microplastic and nanoplastic exposure and the two most common neurodegenerative diseases — Alzheimer's and Parkinson's — finding evidence that oxidative stress, neuroinflammation, blood-brain barrier disruption, and protein aggregation are key pathways connecting plastic pollution to neurodegeneration.
Do microplastics play a role in the pathogenesis of neurodegenerative diseases? Shared pathophysiological pathways for Alzheimer’s and Parkinson’s disease
This review explores the emerging connection between microplastic exposure and neurodegenerative diseases such as Alzheimer's and Parkinson's, identifying shared pathophysiological pathways. Researchers found that microplastics can cross the blood-brain barrier and may trigger oxidative stress, neuroinflammation, and protein aggregation, which are hallmarks of these conditions. The study suggests that chronic microplastic exposure could be a contributing environmental factor in neurodegeneration, though direct causal evidence in humans is still lacking.
Exposome and unhealthy aging: environmental drivers from air pollution to occupational exposures
Researchers reviewed how environmental exposures over a lifetime — including air pollution, pesticides, heavy metals, and other toxicants — accelerate aging and raise the risk of cardiovascular disease, Alzheimer's, and Parkinson's disease, in part by crossing the blood-brain barrier and triggering inflammation. Understanding these exposome-aging links is key to developing strategies that protect brain and heart health as populations grow older.